Invalid News Story.
CEO Peter Dolan

CEO Peter Dolan

CEO Peter Dolan has been the chief executive officer of Bristol-Myers Squibb Co since 2001. He is 50 years old. Follow Mr. Dolan and Bristol-Myers Squibb Co in the news and blogs or share your own opinion about the company and its... [more]

CEO Peter Dolan has been the chief executive officer of Bristol-Myers Squibb Co since 2001. He is 50 years old. Follow Mr. Dolan and Bristol-Myers Squibb Co in the news and blogs or share your own opinion about the company and its leadership.

News
Showing:  Top Stories  -  Archive
Big Pharmas are cutting costs; Bristol-Myers Squibb Co., Wyeth, Pfizer, Merck & Co., Schering-Plough Corp. and GlaxoSmithKline plc have all announced ...  
From news.google.com via Google News. ()
Related news:
More perspectives...
Pfizer Inc. (PFE) recently reported strong profits on flat revenues, and Bristol-Myers Squibb Co. (BMY) is effectively reinventing itself by embracing ...  
From news.google.com via Google News. ()
Related news:
More perspectives...
BOSTON (Reuters) - Bristol-Myers Squibb Co (BMY.N: Quote, Profile, Research, Stock Buzz) is taking steps to strengthen its balance sheet by as much as $1 ...  
From news.google.com via Google News. ()
More perspectives...
(MRK) and Bristol-Myers Squibb Co. (BMY) told biotechnology executives and venture-capitalists at a conference this week they envision an acceleration of ...  
From news.google.com via Google News. ()
More perspectives...
O’Melveny & Myers is one of the largest lobbying firms in Washington, representing oil giant Hess Corp., Occidental Petroleum and Bristol-Myers Squibb Co. ...  
From news.google.com via Google News. ()
More perspectives...
Sponsors
Bristol-Myers Squibb co-develops and co-commercializes ERBITUX in North America through an agreement with ImClone Systems Incorporated. ...  
From news.google.com via Google News. ()
Related news:
More perspectives...
Bristol-Myers Squibb Co., of New York, is the last major drugmaker still developing a similar medicine, according to Bloomberg data. ...  
From news.google.com via Google News. ()
More perspectives...
Good day everyone and welcome to today's Third Quarter 2008 Earnings Release Conference Call. This call is being recoded. At this time I would like to hand ...  
From news.google.com via Google News. ()
Related news:
More perspectives...
... a standard treatment sold as Sustiva by Bristol-Myers Squibb Co., according to a 48-week Merck-funded study reported today in Washington. ...  
From news.google.com via Google News. ()
More perspectives...
... take a chance and go into areas that no-one else is in," said Jeremy Levin, senior vice president of strategic transactions at Bristol-Myers Squibb Co. ...  
From news.google.com via Google News. ()
More perspectives...
Drug developer Bristol-Myers Squibb Co. offered $4.5 billion in cash for its cancer drug partner ImClone Systems Inc. Thursday.  
From msnbc.msn.com ()
More perspectives...
GlaxoSmithKline, Johnson & Johnson, Merck & Co. and Bristol-Myers Squibb Co. have all started more flexible, focused units to some extent.  
From news.google.com via Google News. ()
More perspectives...
This analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy ...  
From news.google.com via Google News. ()
More perspectives...
That puts it in place to compete for purchases with Pfizer Inc., Bristol-Myers Squibb Co. and Wyeth, three drugmakers that pledged last month to step up ...  
From news.google.com via Google News. ()
More perspectives...
Bristol-Myers Squibb Co. agreed to pay $300 million in a deal to defer federal prosecution of a conspiracy charge stemming from an accounting scandal, the company said Wednesday.  
From msnbc.msn.com ()
More perspectives...
You can improve this news page by changing its keywords and content sources.
Edit News
Sponsors
Top Money Articles
What Obama May Mean for Stocks
Barack Obama won the election in a landslide. Now what can we expect from Wallstreet?
The Real Estate Effects of the Wall Street Mess
Wallstreet may be sitting on top of a billions bailout, but that won't exactly help you pay the mortgage!
Sony Chases Apple's Magic
Suburban hipsters have adopted Apple as one of their own. How can Sony makes its way into the love-fest?
More From Zimbio
Copyright © 2008 - Zimbio, Inc. Some rights reserved.